Viewing Study NCT04602533


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-03-13 @ 4:08 PM
Study NCT ID: NCT04602533
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-17
First Post: 2020-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
Sponsor: Michael Hopp
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer Limited Stage View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LD-SCLC View
None lung cancer View
None durvalumab View